Search

Your search keyword '"Bird, Steven T."' showing total 7 results
Start Over Author "Bird, Steven T." Publisher wiley
7 results on '"Bird, Steven T."'

1. Utility of fertility procedures and prenatal tests to estimate gestational age for live‐births and stillbirths in electronic health plan databases

Author

Taylor, Lockwood G., primary, Bird, Steven T., additional, Stojanovic, Danijela, additional, Toh, Sengwee, additional, Maro, Judith C., additional, Fazio‐Eynullayeva, Elnara, additional, Petrone, Andrew B., additional, Rajbhandari, Rajani, additional, Andrade, Susan E., additional, Haynes, Kevin, additional, McMahill‐Walraven, Cheryl N., additional, Shinde, Mayura, additional, and Lyons, Jennifer G., additional

Published
2022
Full Text
View/download PDF

2. Validation of an ICD ‐10‐based algorithm to identify stillbirth in the Sentinel System

Author

Andrade, Susan E., primary, Shinde, Mayura, additional, Moore Simas, Tiffany A., additional, Bird, Steven T., additional, Bohn, Justin, additional, Haynes, Kevin, additional, Taylor, Lockwood G., additional, Lauring, Julianne R., additional, Longley, Erin, additional, McMahill‐Walraven, Cheryl N., additional, Trinacty, Connie M., additional, Saphirak, Cassandra, additional, Delude, Christopher, additional, DeLuccia, Sandra, additional, Zhang, Tancy, additional, Cole, David V., additional, DiNunzio, Nina, additional, Gertz, Autumn, additional, Fazio‐Eynullayeva, Elnara, additional, and Stojanovic, Danijela, additional

Published
2021
Full Text
View/download PDF

7. A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection.

Author

Gelperin K, Hammad H, Leishear K, Bird ST, Taylor L, Hampp C, and Sahin L

Subjects
Female, Humans, Pregnancy, Registries, Research Design, Sample Size, Systematic Reviews as Topic, Teratogens toxicity, United States, United States Food and Drug Administration, Abnormalities, Drug-Induced epidemiology, Pregnancy Complications epidemiology, Pregnancy Outcome epidemiology
Abstract

Purpose: Our study sought to systematically evaluate protocol-specified study methodology in prospective pregnancy exposure registries including pre-specified pregnancy outcomes, power calculations for sample size, and comparator group selection., Methods: U.S. pregnancy exposure registries designed to evaluate safety of drugs or biologics were identified from www.clinicaltrials.gov, the FDA's Office of Women's Health website, and the FDA's list of postmarketing studies. Protocols or similar documentation were obtained., Results: We identified 35 U.S. registries for drugs or biologic use during pregnancy. All registries assessed risk for overall major congenital malformations. Pre-specified target enrollment was stated for 18 (51%) registries, and ranged from 150 to 500 exposed pregnancies (median 300). Thirty-two (91%) registries identified at least one comparison group, but only nine (26%) planned to use an internal comparator. The most common external comparator group (n = 24, 69%) was the Metropolitan Atlanta Congenital Defects Program (MACDP)., Conclusions: No registries were designed to have sufficient power to assess specific malformations, despite the plausibility that most teratogens cause specific defects. Only half of the registries included a power analysis. Despite their common use, external comparators, including MACDP, have important limitations. In the absence of randomized controlled trial data in pregnant women, pregnancy registries remain an important tool as part of a comprehensive pregnancy surveillance program; however, pregnancy registries alone may not be sufficient to obtain adequate data regarding risks of specific malformations. Published 2016. This article is a U.S. Government work and is in the public domain in the USA., (Published 2016. This article is a U.S. Government work and is in the public domain in the USA.)

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results